←Back to structures
KY065497.1__APD24141.1__IPP61_00031__00031
Bact-VirKY065497.1__APD24141.1__IPP61_00031__00031
Identity
- Accession:
- KY065497 ↗
- Kingdom:
- phage
Quality
85.2
mean pLDDT
Taxonomy
TaxID: 1916197
Cluster
Singleton — not in a non-trivial cluster
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 78-195
Domain cluster:
rep: MN270258.1__QGJ85309.1__X__00082__D64-191
Pfam (1)
| Accession | Name | Score | E-value | Q cov | HMM cov |
|---|---|---|---|---|---|
| PF12642.14 best | TpcC | 106.5 | 2.70e-30 | 94.9% | 48.3% |
CATH (69)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3ub1A01 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.86 | 82.0 | 7.74e-01 | 100.0% | 88.2% |
| 4ec6A00 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.86 | 71.0 | 7.44e-01 | 100.0% | 94.5% |
| 3ub1D02 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.85 | 68.0 | 6.95e-01 | 100.0% | 86.0% |
| 7pkwA01 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.84 | 60.0 | 6.47e-01 | 95.8% | 84.5% |
| 4o3vA00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.81 | 76.0 | 7.16e-01 | 100.0% | 93.5% |
| 2cc3A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.81 | 75.0 | 7.01e-01 | 100.0% | 91.7% |
| 4jf8A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.79 | 74.0 | 6.85e-01 | 100.0% | 92.4% |
| 4kz1A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.78 | 73.0 | 6.97e-01 | 100.0% | 99.3% |
| 7c5yA02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 72.0 | 6.53e-01 | 100.0% | 100.0% |
| 3d9rB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 71.0 | 6.83e-01 | 100.0% | 92.5% |
| 1wnhA02 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 51.0 | 5.14e-01 | 100.0% | 67.5% |
| 3soyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 71.0 | 6.62e-01 | 100.0% | 88.7% |
| 2lyxA00 | 3.10.450.390 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › Protein of unknown function DUF3889 | 0.75 | 47.0 | 5.35e-01 | 96.6% | 85.1% |
| 3a76A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 69.0 | 6.51e-01 | 100.0% | 90.6% |
| 1tp6A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 68.0 | 6.70e-01 | 99.2% | 97.6% |
| 2bmoB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 68.0 | 5.73e-01 | 100.0% | 77.3% |
| 3ef8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 69.0 | 6.33e-01 | 100.0% | 82.4% |
| 2b1xB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 68.0 | 6.04e-01 | 100.0% | 87.4% |
| 5ig0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 69.0 | 6.62e-01 | 100.0% | 95.4% |
| 3robA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 68.0 | 6.53e-01 | 100.0% | 91.6% |
| 3e99A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 67.0 | 6.18e-01 | 100.0% | 90.5% |
| 3hzpA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 66.0 | 6.48e-01 | 100.0% | 91.3% |
| 4l8oA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 67.0 | 5.93e-01 | 100.0% | 75.0% |
| 5bkaE01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 66.0 | 6.40e-01 | 100.0% | 97.0% |
| 1uliB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 67.0 | 5.77e-01 | 100.0% | 85.3% |
| 1c7hA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 64.0 | 6.33e-01 | 100.0% | 91.1% |
| 3ebyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 66.0 | 6.05e-01 | 100.0% | 87.6% |
| 2bngC00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 62.0 | 5.89e-01 | 100.0% | 78.6% |
| 1of5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 66.0 | 6.03e-01 | 100.0% | 82.5% |
| 2i9wA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 60.0 | 5.24e-01 | 96.6% | 60.8% |
| 5cxoB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 65.0 | 6.26e-01 | 100.0% | 88.1% |
| 3k0zA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 65.0 | 5.96e-01 | 100.0% | 78.5% |
| 3rgaA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 65.0 | 6.27e-01 | 100.0% | 88.7% |
| 3eyrA00 | 3.15.10.40 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Uncharacterised protein PF07273 family, DUF1439 | 0.70 | 51.0 | 4.53e-01 | 100.0% | 53.3% |
| 3mg1B02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 63.0 | 6.21e-01 | 100.0% | 92.0% |
| 3b7cA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 64.0 | 6.44e-01 | 100.0% | 99.2% |
| 3fsdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 64.0 | 6.38e-01 | 100.0% | 97.5% |
| 3cu3A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 63.0 | 5.69e-01 | 100.0% | 78.4% |
| 3bb9B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 64.0 | 6.27e-01 | 100.0% | 97.6% |
| 3f7xA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 64.0 | 6.14e-01 | 99.2% | 91.7% |
| 1nu3A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 61.0 | 5.73e-01 | 100.0% | 78.6% |
| 1vqqA01 | 3.10.450.100 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › NTF2-like; domain 1 | 0.69 | 59.0 | 6.14e-01 | 100.0% | 100.0% |
| 4ak1A02 | 2.30.30.1270 | Mainly Beta › Roll › SH3 type barrels. › | 0.69 | 34.0 | 4.49e-01 | 78.0% | 87.5% |
| 2r4iA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 63.0 | 6.23e-01 | 100.0% | 95.1% |
| 2gtlN02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.69 | 47.0 | 4.20e-01 | 100.0% | 49.4% |
| 3dmcA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 63.0 | 6.06e-01 | 100.0% | 89.6% |
| 1tuhA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 62.0 | 6.02e-01 | 100.0% | 89.3% |
| 3ke7B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 61.0 | 5.90e-01 | 100.0% | 86.5% |
| 3kspA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 61.0 | 5.95e-01 | 100.0% | 90.7% |
| 1s5aB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 62.0 | 5.78e-01 | 100.0% | 84.6% |
| 2gtlO02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.67 | 47.0 | 4.19e-01 | 100.0% | 51.5% |
| 3g8zA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 61.0 | 5.94e-01 | 98.3% | 90.6% |
| 4h3uA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 58.0 | 5.69e-01 | 99.2% | 86.9% |
| 4j8tA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 60.0 | 5.88e-01 | 99.2% | 93.0% |
| 3dm8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 60.0 | 5.73e-01 | 100.0% | 91.1% |
| 3grdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 60.0 | 5.79e-01 | 99.2% | 90.9% |
| 3fgyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 59.0 | 5.66e-01 | 100.0% | 86.7% |
| 3ff2A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 53.0 | 5.35e-01 | 100.0% | 98.3% |
| 3hk4A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 52.0 | 5.30e-01 | 100.0% | 96.6% |
| 3ec9A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 53.0 | 5.20e-01 | 100.0% | 90.7% |
| 1bp1A01 | 3.15.10.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Bactericidal permeability-increasing protein; domain 1 | 0.60 | 55.0 | 4.73e-01 | 100.0% | 68.9% |
| 4q0yA00 | 2.60.40.4400 | Mainly Beta › Sandwich › Immunoglobulin-like › | 0.58 | 39.0 | 3.76e-01 | 96.6% | 60.3% |
| 4eg9A00 | 2.50.20.40 | Mainly Beta › Clam › outer membrane lipoprotein receptor (LolB), chain A › | 0.58 | 52.0 | 4.21e-01 | 100.0% | 88.3% |
| 2rckA01 | 3.15.10.30 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › TULIP domain | 0.57 | 52.0 | 4.26e-01 | 100.0% | 61.9% |
| 2obdA01 | 3.15.20.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 2 › Bactericidal permeability-increasing protein; domain 2 | 0.56 | 50.0 | 3.84e-01 | 100.0% | 42.8% |
| 3h4zB03 | 3.15.10.50 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › | 0.56 | 52.0 | 4.38e-01 | 100.0% | 64.9% |
| 4rlcA00 | 2.40.160.20 | Mainly Beta › Beta Barrel › Porin › | 0.55 | 50.0 | 4.79e-01 | 100.0% | 85.9% |
| 2xzmE01 | 3.30.160.20 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › | 0.51 | 39.0 | 3.94e-01 | 78.8% | 98.3% |
| 2amhA00 | 3.90.950.10 | Alpha Beta › Alpha-Beta Complex › Maf protein › | 0.51 | 40.0 | 3.43e-01 | 83.9% | 92.3% |
ECOD (82)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3588474 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.99 | 97.0 | 9.64e-01 | 100.0% | 97.5% |
| 3962486 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.85 | 80.0 | 7.21e-01 | 100.0% | 79.2% |
| 4254866 | 243.1.1.66 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TcaA_5th | 0.84 | 78.0 | 7.65e-01 | 99.2% | 92.0% |
| 3952458 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.82 | 75.0 | 7.26e-01 | 100.0% | 89.2% |
| 4987319 | 1036.1.1.2 ↗ | a+b two layers › 60S ribosomal export protein NMD3 a+b domain › 60S ribosomal export protein NMD3 a+b domain › 60S ribosomal export protein NMD3 a+b domain › PF29994 | 0.81 | 51.0 | 5.27e-01 | 90.7% | 67.3% |
| 4152363 | 243.1.1.115 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29733 | 0.81 | 74.0 | 7.34e-01 | 100.0% | 93.5% |
| 1674783 | 243.1.1.15 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › T4BSS_DotI_IcmL | 0.81 | 76.0 | 7.13e-01 | 100.0% | 92.8% |
| 4436162 | 243.1.1.34 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › YchJ_M-like | 0.80 | 62.0 | 6.03e-01 | 98.3% | 73.8% |
| 5040972 | 295.1.1.0 ↗ | a+b two layers › ssDNA-binding transcriptional regulator domain-like › ssDNA-binding transcriptional regulator domain › ssDNA-binding transcriptional regulator domain | 0.80 | 42.0 | 5.14e-01 | 84.7% | 80.0% |
| 3588483 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.79 | 74.0 | 7.05e-01 | 100.0% | 92.5% |
| 3736480 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.77 | 71.0 | 6.48e-01 | 100.0% | 90.3% |
| 3290450 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.77 | 72.0 | 6.68e-01 | 100.0% | 86.7% |
| 3967817 | 243.1.1.34 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › YchJ_M-like | 0.77 | 63.0 | 6.18e-01 | 96.6% | 81.6% |
| 3970236 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.76 | 71.0 | 6.72e-01 | 100.0% | 89.2% |
| 4664932 | 243.1.1.34 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › YchJ_M-like | 0.76 | 61.0 | 6.05e-01 | 96.6% | 80.0% |
| 6405 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.76 | 71.0 | 6.85e-01 | 100.0% | 93.2% |
| 4582733 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.76 | 63.0 | 6.15e-01 | 100.0% | 80.0% |
| 3974899 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.76 | 71.0 | 6.55e-01 | 100.0% | 87.6% |
| 3970009 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.75 | 69.0 | 6.11e-01 | 100.0% | 84.6% |
| 4608992 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.75 | 69.0 | 6.25e-01 | 100.0% | 91.1% |
| 4193401 | 243.1.1.34 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › YchJ_M-like | 0.75 | 63.0 | 6.55e-01 | 100.0% | 96.4% |
| 3971296 | 243.1.1.5 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Tim44 | 0.75 | 68.0 | 6.65e-01 | 100.0% | 90.7% |
| 3698353 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.75 | 70.0 | 6.85e-01 | 100.0% | 96.8% |
| 4315252 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.75 | 69.0 | 6.42e-01 | 100.0% | 85.5% |
| 5022156 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.74 | 69.0 | 6.54e-01 | 100.0% | 89.1% |
| 4950139 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.74 | 69.0 | 6.79e-01 | 100.0% | 96.0% |
| 4283272 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.74 | 68.0 | 6.00e-01 | 100.0% | 83.5% |
| 6408 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.74 | 69.0 | 6.32e-01 | 100.0% | 81.9% |
| 3277629 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.74 | 68.0 | 6.70e-01 | 100.0% | 100.0% |
| 3056323 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.74 | 68.0 | 6.13e-01 | 100.0% | 89.2% |
| 3283278 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.74 | 68.0 | 6.52e-01 | 100.0% | 93.3% |
| 143237 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.73 | 68.0 | 6.53e-01 | 100.0% | 91.6% |
| 4676601 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.73 | 68.0 | 5.94e-01 | 100.0% | 85.2% |
| 5009713 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.73 | 67.0 | 6.03e-01 | 100.0% | 90.6% |
| 3281901 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.73 | 67.0 | 6.27e-01 | 100.0% | 87.6% |
| 3734807 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 67.0 | 5.85e-01 | 100.0% | 68.2% |
| 5059048 | 243.1.1.13 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › CaMKII_AD | 0.73 | 68.0 | 6.69e-01 | 100.0% | 99.2% |
| 3808862 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.73 | 67.0 | 6.36e-01 | 100.0% | 88.4% |
| 5003871 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.73 | 67.0 | 6.33e-01 | 100.0% | 92.9% |
| 135548 | 243.1.1.19 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF3804 | 0.72 | 66.0 | 6.46e-01 | 100.0% | 90.6% |
| 4884000 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.72 | 64.0 | 5.83e-01 | 95.8% | 90.4% |
| 3710733 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.72 | 66.0 | 6.63e-01 | 100.0% | 97.5% |
| 3930653 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.72 | 49.0 | 5.53e-01 | 100.0% | 92.2% |
| 3940802 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.72 | 55.0 | 5.77e-01 | 100.0% | 89.5% |
| 3519929 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.71 | 66.0 | 6.40e-01 | 100.0% | 90.8% |
| 4020443 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.71 | 66.0 | 6.53e-01 | 100.0% | 95.9% |
| 3826602 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.71 | 66.0 | 6.19e-01 | 100.0% | 87.1% |
| 4097328 | 9.3.1.3 ↗ | beta barrels › Lipocalins/Streptavidin › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Eryth_link_C | 0.71 | 48.0 | 4.78e-01 | 99.2% | 65.6% |
| 4927181 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.71 | 65.0 | 6.36e-01 | 100.0% | 93.0% |
| 3828738 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.71 | 65.0 | 5.91e-01 | 100.0% | 81.9% |
| 137905 | 883.1.1.5 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › DUF1439 | 0.70 | 52.0 | 4.53e-01 | 100.0% | 52.6% |
| 3278323 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.70 | 64.0 | 6.19e-01 | 100.0% | 89.2% |
| 3307679 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.70 | 65.0 | 6.12e-01 | 100.0% | 84.3% |
| 3731745 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.70 | 64.0 | 5.77e-01 | 100.0% | 78.1% |
| 170212 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.69 | 64.0 | 6.38e-01 | 100.0% | 97.5% |
| 3453643 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.69 | 64.0 | 5.98e-01 | 100.0% | 82.8% |
| 3262201 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 62.0 | 5.83e-01 | 100.0% | 80.0% |
| 3959349 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.69 | 63.0 | 6.07e-01 | 99.2% | 90.3% |
| 4074364 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 57.0 | 5.52e-01 | 98.3% | 81.5% |
| 3280539 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.68 | 63.0 | 6.11e-01 | 100.0% | 93.1% |
| 6390 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.68 | 62.0 | 6.23e-01 | 100.0% | 99.2% |
| 137634 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.68 | 61.0 | 5.95e-01 | 100.0% | 90.7% |
| 3818687 | 243.1.1.49 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2358 | 0.67 | 60.0 | 5.61e-01 | 100.0% | 79.3% |
| 5017300 | 283.2.1.0 ↗ | a+b duplicates or obligate multimers › Creatinase/aminopeptidase-like › gpW/gp25-like › gpW/gp25-like | 0.66 | 42.0 | 4.26e-01 | 94.9% | 63.3% |
| 3226411 | 243.1.1.82 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26529 | 0.64 | 58.0 | 5.38e-01 | 100.0% | 94.0% |
| 3764436 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.62 | 53.0 | 4.62e-01 | 100.0% | 61.1% |
| 3760087 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.61 | 48.0 | 4.00e-01 | 83.1% | 70.2% |
| 3285112 | 883.1.1.0 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like | 0.61 | 49.0 | 4.15e-01 | 100.0% | 53.2% |
| 3773175 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.60 | 50.0 | 4.25e-01 | 100.0% | 55.7% |
| 4603160 | 5084.5.4.4 ↗ | beta barrels › Outer membrane meander beta-barrels › Porins › Outer membrane protein transport protein › YaiO | 0.60 | 39.0 | 3.13e-01 | 100.0% | 32.8% |
| 3432106 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.58 | 50.0 | 5.03e-01 | 99.2% | 91.0% |
| 4647627 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.57 | 51.0 | 4.23e-01 | 100.0% | 58.6% |
| 5023738 | 11.1.1.1443 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like › PF29994 | 0.56 | 44.0 | 4.60e-01 | 90.7% | 90.0% |
| 3433417 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.56 | 45.0 | 4.70e-01 | 99.2% | 97.1% |
| 3569021 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.55 | 50.0 | 4.31e-01 | 100.0% | 65.4% |
| 3807704 | 11.1.1.0 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like | 0.54 | 49.0 | 4.56e-01 | 98.3% | 84.0% |
| 3429034 | 11.1.1.51 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like › LEA_2 | 0.54 | 49.0 | 4.36e-01 | 97.5% | 76.4% |
| 3407434 | 206.1.1.55 ↗ | a+b complex topology › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase › EcKL | 0.54 | 48.0 | 3.24e-01 | 95.8% | 31.1% |
| 3833052 | 11.1.1.51 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like › LEA_2 | 0.54 | 49.0 | 4.31e-01 | 100.0% | 74.0% |
| 3255279 | 5.1.4.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed | 0.52 | 46.0 | 3.16e-01 | 100.0% | 40.9% |
| 3409664 | 206.1.1.55 ↗ | a+b complex topology › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase › EcKL | 0.52 | 47.0 | 3.21e-01 | 100.0% | 32.9% |
| 3389001 | 883.1.1.3 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › JHBP | 0.51 | 46.0 | 3.74e-01 | 100.0% | 61.7% |
D2
high
residues 216-308
Domain cluster:
rep: MF172979.1__ASD51117.1__SER90K_60__00060__D2-92
Pfam (1)
| Accession | Name | Score | E-value | Q cov | HMM cov |
|---|---|---|---|---|---|
| PF12642.14 best | TpcC | 87.7 | 1.50e-24 | 100.0% | 40.0% |